TabletsMRP Under Process
Official PMBI MRP is being updated for catalog code 2804.
Locate Jan Aushadhi KendraClinical Overview
Clonazepam and Propranolol is a psychotropic and autonomic regulator combination. Clonazepam provides sustained central anxiolysis and neuronal stabilization via GABAA chloride conductance, while propranolol blocks peripheral beta-adrenergic receptors, stopping autonomic hyperarousal (tremors, racing heartbeat, flushing). Indicated for social phobia, severe panic attacks, stage fright, and anxiety disorders characterized by palpitations and tremor.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Swallow whole with water, with or without food. Take on schedule as prescribed. Never discontinue abruptly; taper gradually to prevent rebound hypertension and withdrawal seizures.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, bradycardia, dizziness, cold extremities, fatigue, ataxia. Rare/Severe: Severe bronchospasm, heart block, respiratory depression, and paradoxical excitation.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in asthma, severe sinus bradycardia, second- or third-degree heart block, and myasthenia gravis. Boxed warnings for dependence and withdrawal. Avoid alcohol.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Clonazepam Tablets 0.5 mg
Clonazepam is a long-acting benzodiazepine with potent anticonvulsant, muscle-relaxant, and anxiolytic actions on the WHO Model List of Essential Medicines. It allosterically modulates GABAA receptors, increasing frequency of chloride channel opening and dampening epileptic foci in the cortex and limbic system. Indicated for panic disorder with or without agoraphobia, Lennox-Gastaut syndrome, myoclonic and akinetic seizures, and absence seizures refractory to succinimides.
Propranolol Tablets 40 mg
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Escitalopram Oxelate 10mg + Clonazepam 0.5mg Tablets
Clonazepam and Escitalopram is a premier neuropsychiatric fixed-dose combination. Escitalopram, a high-affinity SSRI, selectively inhibits presynaptic serotonin reuptake to treat core depression and panic circuitry over time, while clonazepam, a long-acting benzodiazepine, delivers immediate allosteric enhancement of GABAA receptors, dampening initial SSRI-induced jitteriness, insomnia, and acute anxiety. Indicated for major depressive disorder with comorbid anxiety, panic disorder, and generalized anxiety disorder.
Clonazepam Tablets 1mg
Clonazepam is a long-acting benzodiazepine with potent anticonvulsant, muscle-relaxant, and anxiolytic actions on the WHO Model List of Essential Medicines. It allosterically modulates GABAA receptors, increasing frequency of chloride channel opening and dampening epileptic foci in the cortex and limbic system. Indicated for panic disorder with or without agoraphobia, Lennox-Gastaut syndrome, myoclonic and akinetic seizures, and absence seizures refractory to succinimides.